HOME >> BIOLOGY >> NEWS
Progress toward a targeted therapy for a specific form of leukemia

Leuven, Belgium -- Leukemia, or cancer of the bone marrow, strikes some 700 Belgians each year. Scientists are still searching for the cause of many forms of leukemia, including T-cell acute lymphoblastic leukemia, or T-ALL. Now, VIB researchers connected to the Katholieke Universiteit Leuven have identified a new player in the development of some 10% of the T-ALL cases: MYB. The scientists have discovered that patients in this group have a duplication of the MYB gene, which increases MYB concentrations. Further research has indicated that MYB might well be an important target for therapies for this group of T-ALL patients.

T-cell acute lymphoblastic leukemia (T-ALL)

Our bodies white blood cells combat foreign intruders such as viruses and bacteria. However, in leukemia, the formation of white blood cells is disrupted. The cells in the bone marrow that should develop into white blood cells multiply out of control without fully maturing. These blood cells do not function properly and thus jeopardize the production of normal blood cells. Among other consequences, this makes patients more susceptible to infections. T-ALL is a certain form of leukemia in which immature T-cells (a specific type of blood cells) build up very rapidly. T-ALL is the most prevalent form of cancer in children under 14 years of age, striking children between the ages of 2 and 3 in particular. Today, with optimal treatment using chemotherapy, more than half of the children are cured.

Combined action of several players

The search for the mechanisms that cause T-ALL goes on ceaselessly. Discovering these mechanisms will enable the development of targeted therapies, which are preferred over chemotherapy. Scientists know that T-ALL arises only when defects occur in several genes simultaneously. So it is not only important to identify the genes that underlie T-ALL, but also to discover which combinations trigger the disease. This is an important step in
'"/>

Contact: Ann Van Gysel
info@vib.be
329-244-6611
VIB, Flanders Interuniversity Institute of Biotechnology
15-Apr-2007


Page: 1 2 3

Related biology news :

1. Breast cancer milieu -- Progression, tamoxifen sensitivity, and DNA reversion
2. Progress against sarcoma
3. Progress toward artificial photosynthesis?
4. 2nd annual Albert Szent-Gyrgyi Prize for Progress in Cancer Research awarded to Webster K. Cavenee
5. Progress in battle against life-threatening acute allergy
6. Progress report on Homogeneous Assay project
7. Progress being made in exploring potential use of stem cells to treat heart disease
8. Media Invite: Dinner to award prize for Progress in Cancer Research
9. Progress needed on global regime for access to genetic resources and benefit-sharing
10. Albert Szent-Gyrgyi Prize for Progress in Cancer Research announced
11. Progress toward a new remedy for chronic urinary tract infections?

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/4/2019)... ... August 02, 2019 , ... Bioclinica, ... industry in advancing the development of medical therapies, announced today that Michael O’Neal, ... as one of the “100 Most Inspiring People in the Life-Sciences Industry.” ...
(Date:8/1/2019)... ... August 01, 2019 , ... John R. Freeman, CPA, has joined ... founder and president of BioLabs, which provides premier co-working spaces for life science startups ... our ability to forecast and manage growth,” says Fruehauf. “BioLabs has expanded to 10 ...
(Date:8/1/2019)... ... July 31, 2019 , ... Molecular Devices, LLC, a leader ... generation of its FLIPR® Penta High-Throughput Cellular Screening System. , The new FLIPR ... of G-protein-coupled receptors (GPCRs) and ion channels, offering a new high-speed camera option ...
Breaking Biology News(10 mins):
(Date:7/9/2019)... ... July 08, 2019 , ... ... SmartLight Indicator was recognized as the 2019 Innovative Product of the Year which ... prestigious awards were during Sensors Expo & Conference 2019, held this ...
(Date:6/12/2019)... ... June 12, 2019 , ... ... leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries, ... been signed. The agreement will grant exclusive rights for Zillion to represent LDA ...
(Date:6/11/2019)... ... June 11, 2019 , ... Veterinary Regenerative ... Inc. (PSC) , has announced that their GMP facility for cell production is ... for manufacturing. This is an important milestone for VetStem as it expands ...
(Date:5/31/2019)... ... May 30, 2019 , ... ... on Data Integrity on July 08-09, 2019 in Boston, MA. This peer recommended ... medical device organizations. , The training will kick off with a compendial treatment ...
Breaking Biology Technology:
Cached News: